News

The A-FLUX Reducer System from VahatiCor is designed to treat coronary microvascular dysfunction.

The self-expanding A-Flux device is implanted in the coronary sinus to increase pressure on the venous side of the heart and improve perfusion in smaller vessels.

Impella users need to monitor for blood leaks at the sidearm and hub of the introducer sheath shown below here introducers.

Eight reports of major bleeding have been reported from Impella introducers, prompting the FDA early alert this week. 

Devi Nair, MD, director of electrophysiology and research at St. Bernards Medical Center and the Arrhythmia Research Group, explains new technology advances in leadless pacing for conduction pacing and Bachmann's bundle pacing.

Leadless pacing in the Bachmann's bundle may be the next phase in the evolution of cardiac pacing technology.

 

Midjourney ultrasound scanning whole-body ultrasonic CT

Radiologists, meanwhile, took to social media to criticize the endeavor, noting that the generative AI company lacks clinical evidence to back its marketing claims. 

The proportion of radiologists performing some (>0%) IR-related work declined from 70% in 2008 down to 50% by 2023, according to new research published in JVIR. 

lung cancer screening low-dose CT

While overall lung cancer rates are declining, cases among nonsmoking women are on the rise, puzzling scientists.   

family in supermarket

One of the largest food retailers in the world—and the fourth biggest in this country—got itself into hot water with the U.S. Department of Justice for allegedly cheating on drug prices it charges to federal healthcare programs.

legal liability malpractice artificial intelligence

Tamin Naber, MD, was charged with simple assault for biting a former employee at his medical practice who was suing him for wrongful termination. The incident occurred in November 2025. 

doctor looking at CLTI patient's leg

Atherectomy is associated with rising healthcare costs, making it important to learn as much about the procedure's long-term value as possible. 

Abbott recently announced it is partnering with AtaCor Medical to develop a next-generation extravascular implantable cardioverter defibrillator (EV-ICD) system. AtaCor's investigational extravascular ICD lead will be paired with Abbott's investigational extravascular ICD system.

Extravascular ICDs were developed to avoid complications such as vascular injuries, lead fractures and lead infections. Although rare, these issues can cause serious, life-threatening complications for patients.

Lung cancer screening stethoscope

Medical societies representing all three specialties issued a joint statement Jan. 21, criticizing studies claiming such scans pose risk of potential patient harm. 

breast cancer mammography mammogram

Researchers with UT Southwestern Medical Center recently surveyed over 900 women about how they view the technology's deployment in screening. 

Around the web

The self-expanding A-Flux device is implanted in the coronary sinus to increase pressure on the venous side of the heart and improve perfusion in smaller vessels.

Eight reports of major bleeding have been reported from Impella introducers, prompting the FDA early alert this week. 

Leadless pacing in the Bachmann's bundle may be the next phase in the evolution of cardiac pacing technology.